ClinicalTrials.govpublic full text
Irreversible Electroporation (IRE) Followed by Nivolumab in Patients With Metastatic Pancreatic Cancer.
metastatic pancreatic cancer, irreversible electroporation (ire), nivolumab, phase ii trial, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 840375
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.